ATAD1 | ATPase family, AAA domain containing 1 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ATF6 | Activating transcription factor 6 | Plasma proteins Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
ATF6B | Activating transcription factor 6 beta | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
ATF7 | Activating transcription factor 7 | Predicted intracellular proteins Predicted membrane proteins Transcription factors
| | | | | Expressed in all |
ATG9A | Autophagy related 9A | Predicted membrane proteins
| | | | | Expressed in all |
ATM | ATM serine/threonine kinase | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP10A | ATPase, class V, type 10A | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Mixed |
ATP11B | ATPase, class VI, type 11B | Enzymes Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP13A2 | ATPase type 13A2 | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP13A3 | ATPase type 13A3 | Predicted membrane proteins
| | | | | Expressed in all |
ATP13A5 | ATPase type 13A5 | Predicted membrane proteins
| | | | | Tissue enhanced |
ATP1A1 | ATPase, Na+/K+ transporting, alpha 1 polypeptide | Cancer-related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP1B1 | ATPase, Na+/K+ transporting, beta 1 polypeptide | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP1B2 | ATPase, Na+/K+ transporting, beta 2 polypeptide | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
ATP1B3 | ATPase, Na+/K+ transporting, beta 3 polypeptide | CD markers Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP2B1 | ATPase, Ca++ transporting, plasma membrane 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 | Enzymes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP2C1 | ATPase, Ca++ transporting, type 2C, member 1 | Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP4B | ATPase, H+/K+ exchanging, beta polypeptide | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
ATP5J2 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit F2 | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP5L | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP6AP1 | ATPase, H+ transporting, lysosomal accessory protein 1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ATP6AP1L | ATPase, H+ transporting, lysosomal accessory protein 1-like | Predicted membrane proteins
| | | | | Mixed |
ATP6AP2 | ATPase, H+ transporting, lysosomal accessory protein 2 | Disease related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ATP6V0A1 | ATPase, H+ transporting, lysosomal V0 subunit a1 | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ATP6V0A2 | ATPase, H+ transporting, lysosomal V0 subunit a2 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATP8B4 | ATPase, class I, type 8B, member 4 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ATP9B | ATPase, class II, type 9B | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATR | ATR serine/threonine kinase | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATRAID | All-trans retinoic acid-induced differentiation factor | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATRIP | ATR interacting protein | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ATRN | Attractin | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ATRNL1 | Attractin-like 1 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ATXN3 | Ataxin 3 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
AVL9 | AVL9 homolog (S. cerevisiase) | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
AWAT1 | Acyl-CoA wax alcohol acyltransferase 1 | Enzymes Predicted membrane proteins
| | | | | Not detected |
AXL | AXL receptor tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
B3GALT2 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
B3GAT2 | Beta-1,3-glucuronyltransferase 2 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
B3GNT2 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
B4GALNT2 | Beta-1,4-N-acetyl-galactosaminyl transferase 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
B4GALT1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
B4GALT2 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
BACE1 | Beta-site APP-cleaving enzyme 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
BACE2 | Beta-site APP-cleaving enzyme 2 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BAK1 | BCL2-antagonist/killer 1 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
BAMBI | BMP and activin membrane-bound inhibitor | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
BCAM | Basal cell adhesion molecule (Lutheran blood group) | Blood group antigen proteins CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
BCL2L1 | BCL2-like 1 | Cancer-related genes Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins RAS pathway related proteins Transporters
| | | | | Expressed in all |
BCL2L10 | BCL2-like 10 (apoptosis facilitator) | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |